Medtronic Suspends Endurant Evo Study To Investigate Stent Fractures
This article was originally published in The Gray Sheet
The trial of the next-generation abdominal aortic aneurysm stent graft, with potential to broaden the applicability of endovascular AAA repair, was launched in 2015 to support US and international approvals. Medtronic halted the trial with only one patient left to enroll so the firm could take a closer look at unanticipated stent fractures.
Register for our free email digests: